These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 16488571

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vibrational bone characteristics versus bone density for the assessment of osteoporosis in ovariectomized rats.
    Anastassopoulos G, Panteliou S, Christopoulou G, Stavropoulou A, Panagiotopoulos E, Lyritis G, Khaldi L, Varakis J, Karamanos N.
    J Med Eng Technol; 2010 Jan; 34(1):35-42. PubMed ID: 19995148
    [Abstract] [Full Text] [Related]

  • 3. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
    Perifanis V, Vyzantiadis T, Tziomalos K, Vakalopoulou S, Garipidou V, Athanassiou-Metaxa M, Harsoulis F.
    Ann Hematol; 2007 Jan; 86(1):23-30. PubMed ID: 17013645
    [Abstract] [Full Text] [Related]

  • 4. Alteration in serum leptin correlates with alterations in serum N-telopeptide of collagen type I and serum osteocalcin during the progression of osteoporosis in ovariectomized rats.
    Stavropoulou A, Christopoulou GE, Anastassopoulos G, Panteliou SD, Lyritis GP, Spiliotis BE, Karamanos NK, Panagiotopoulos E, Lambiris E.
    Clin Chem Lab Med; 2005 Jan; 43(12):1359-65. PubMed ID: 16309373
    [Abstract] [Full Text] [Related]

  • 5. [Prediction of changes in bone density during alendronate treatment in postmenopausal women].
    Masaryk P, Stancíková M, Letkovská A, Rovenský J.
    Vnitr Lek; 2002 Oct; 48(10):943-7. PubMed ID: 16737141
    [Abstract] [Full Text] [Related]

  • 6. Onion decreases the ovariectomy-induced osteopenia in young adult rats.
    Huang TH, Mühlbauer RC, Tang CH, Chen HI, Chang GL, Huang YW, Lai YT, Lin HS, Yang WT, Yang RS.
    Bone; 2008 Jun; 42(6):1154-63. PubMed ID: 18387868
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E.
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis.
    Papadaki HA, Tsatsanis C, Christoforidou A, Malliaraki N, Psyllaki M, Pontikoglou C, Miliaki M, Margioris AN, Eliopoulos GD.
    J Bone Miner Metab; 2004 Mar; 22(6):577-87. PubMed ID: 15490268
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy.
    Greenspan SL, Holland S, Maitland-Ramsey L, Poku M, Freeman A, Yuan W, Kher U, Gertz B.
    Proc Assoc Am Physicians; 1996 May; 108(3):230-8. PubMed ID: 8774056
    [Abstract] [Full Text] [Related]

  • 14. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, Lüftner D.
    Anticancer Res; 2007 May; 27(4A):1853-62. PubMed ID: 17649784
    [Abstract] [Full Text] [Related]

  • 15. Short-term changes in serum PINP predict long-term changes in trabecular bone in the rat ovariectomy model.
    Rissanen JP, Suominen MI, Peng Z, Morko J, Rasi S, Risteli J, Halleen JM.
    Calcif Tissue Int; 2008 Feb; 82(2):155-61. PubMed ID: 18219436
    [Abstract] [Full Text] [Related]

  • 16. Effect of a short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus.
    Pivonello R, Faggiano A, Di Somma C, Klain M, Filippella M, Salvatore M, Lombardi G, Colao A.
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2349-52. PubMed ID: 10404801
    [Abstract] [Full Text] [Related]

  • 17. Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate.
    Muñoz-Torres M, Reyes-García R, Mezquita-Raya P, Fernández-García D, Alonso G, Luna Jde D, Ruiz-Requena ME, Escobar-Jiménez F.
    Maturitas; 2009 Nov 20; 64(3):188-92. PubMed ID: 19819089
    [Abstract] [Full Text] [Related]

  • 18. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
    Elwakkad AS, El Elshamy KA, Sibaii H.
    Epilepsy Res; 2008 Jul 20; 80(1):47-56. PubMed ID: 18455911
    [Abstract] [Full Text] [Related]

  • 19. Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat.
    Wezeman FH, Emanuele MA, Moskal SF, Steiner J, Lapaglia N.
    J Bone Miner Res; 2000 Oct 20; 15(10):2033-41. PubMed ID: 11028458
    [Abstract] [Full Text] [Related]

  • 20. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K.
    Bone; 2008 Nov 20; 43(5):894-900. PubMed ID: 18687415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.